EA028490B8 - Способ дегликозилирования иммуноглобулина - Google Patents

Способ дегликозилирования иммуноглобулина

Info

Publication number
EA028490B8
EA028490B8 EA201490447A EA201490447A EA028490B8 EA 028490 B8 EA028490 B8 EA 028490B8 EA 201490447 A EA201490447 A EA 201490447A EA 201490447 A EA201490447 A EA 201490447A EA 028490 B8 EA028490 B8 EA 028490B8
Authority
EA
Eurasian Patent Office
Prior art keywords
endos49
igg
mutant
endos
seq
Prior art date
Application number
EA201490447A
Other languages
English (en)
Other versions
EA201490447A1 (ru
EA028490B1 (ru
Inventor
Маттиас Коллин
Мария Аллхорн
Джонатан Сьёгрен
Original Assignee
Дженовис Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дженовис Аб filed Critical Дженовис Аб
Publication of EA201490447A1 publication Critical patent/EA201490447A1/ru
Publication of EA028490B1 publication Critical patent/EA028490B1/ru
Publication of EA028490B8 publication Critical patent/EA028490B8/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01096Mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase (3.2.1.96)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/005Glycopeptides, glycoproteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56944Streptococcus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/40Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41Glycosylation, sialylation, or fucosylation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/20Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Согласно изобретению предложена эндогликозидаза, обозначаемая EndoS49 и имеющая аминокислотную последовательность SEQ ID NO: 1. EndoS49 выделяли из штамма NZ131 Streptococcus pyogenes, она представляет собой гомолог EndoS. EndoS49 обладает специфичной эндогликозидазной активностью в отношении нативного IgG и расщепляет более широкий спектр гликанов Fc, чем EndoS. Получен ее мутант с заменой глутаминовой кислоты в положении 186 SEQ ID NO: 1; указанный мутант не обладает эндогликозидазной активностью, но способен связываться с IgG. Раскрыты способы с применением EndoS49, ее делеций и указанного мутанта особенно для оценки гликозилирования IgG или выделения IgG.
EA201490447A 2011-09-13 2012-09-12 Способ дегликозилирования иммуноглобулина EA028490B8 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB201115841A GB201115841D0 (en) 2011-09-13 2011-09-13 Protein and method
PCT/EP2012/067841 WO2013037824A1 (en) 2011-09-13 2012-09-12 Endoglycosidase from streptococcus pyogenes and methods using it

Publications (3)

Publication Number Publication Date
EA201490447A1 EA201490447A1 (ru) 2014-09-30
EA028490B1 EA028490B1 (ru) 2017-11-30
EA028490B8 true EA028490B8 (ru) 2018-01-31

Family

ID=44908522

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201490447A EA028490B8 (ru) 2011-09-13 2012-09-12 Способ дегликозилирования иммуноглобулина

Country Status (20)

Country Link
US (1) US9493752B2 (ru)
EP (1) EP2756077B1 (ru)
JP (1) JP6076349B2 (ru)
KR (1) KR102001427B1 (ru)
CN (1) CN103946377B (ru)
AU (1) AU2012307461B2 (ru)
BR (1) BR112014005816A2 (ru)
CA (1) CA2848230C (ru)
DK (1) DK2756077T3 (ru)
EA (1) EA028490B8 (ru)
ES (1) ES2627334T3 (ru)
GB (2) GB201115841D0 (ru)
IL (1) IL231410A0 (ru)
IN (1) IN2014CN02163A (ru)
MX (1) MX347727B (ru)
PL (1) PL2756077T3 (ru)
PT (1) PT2756077T (ru)
SG (1) SG11201400505YA (ru)
WO (1) WO2013037824A1 (ru)
ZA (1) ZA201401840B (ru)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1686302A (en) * 2000-12-21 2002-07-01 Shire Biochem Inc Streptococcus pyogenes antigens and corresponding dna fragments
CN110201186A (zh) 2012-10-23 2019-09-06 西纳福克斯股份有限公司 经修饰的抗体、抗体-缀合物及其制备方法
DK2991683T3 (da) 2013-05-02 2019-11-04 Glykos Finland Oy Konjugater af et glykoprotein eller en glykan med en toksisk ladning
US20160235861A1 (en) 2013-10-14 2016-08-18 SynAffix. B.V. Glycoengineered antibody, antibody-conjugate and methods for their preparation
US10072096B2 (en) 2013-10-14 2018-09-11 Synaffix B.V. Modified glycoprotein, protein-conjugate and process for the preparation thereof
US9987373B2 (en) 2013-10-14 2018-06-05 Synaffix B.V. Modified glycoprotein, protein-conjugate and process for the preparation thereof
JP2016538878A (ja) 2013-10-14 2016-12-15 シンアフィックス ビー.ブイ. 糖鎖工学的に操作された抗体、抗体コンジュゲート、及びそれらの調製方法
GB201318490D0 (en) * 2013-10-18 2013-12-04 Genovis Ab Method
US11168085B2 (en) 2014-01-24 2021-11-09 Synaffix B.V. Process for the cycloaddition of a hetero(aryl) 1,3-dipole compound with a (hetero)cycloalkyne
AU2015282627B2 (en) 2014-06-30 2020-04-02 Glykos Finland Oy Saccharide derivative of a toxic payload and antibody conjugates thereof
GB201413240D0 (en) 2014-07-25 2014-09-10 Hansa Medical Ab Method
CN107109454A (zh) 2014-08-04 2017-08-29 西纳福克斯股份有限公司 用β‑(1,4)‑N‑乙酰半乳糖胺转移酶或其突变体修饰糖蛋白的方法
GB201502305D0 (en) * 2015-02-12 2015-04-01 Hansa Medical Ab Protein
GB201502306D0 (en) 2015-02-12 2015-04-01 Hansa Medical Ab Protein
DK3134520T3 (en) 2015-04-23 2018-03-19 Synaffix Bv Process for modifying a glycoprotein using a glycosyltransferase which is or is derived from a (1,4) -N-acetylgalactosaminyltransferase
WO2017124084A1 (en) * 2016-01-15 2017-07-20 University Of Maryland, College Park Endo-s2 mutants as glycosynthases, method of making and use for glycoengineering of glycoproteins
PL3411389T3 (pl) * 2016-02-04 2021-10-25 Genovis Ab Nowe proteazy streptokokowe
TWI727884B (zh) * 2016-08-24 2021-05-11 醣基生醫股份有限公司 利用醣苷內切酶突變體重塑醣蛋白及其使用方法
JP7195008B2 (ja) 2017-05-26 2022-12-23 ジェノビス エービー グリカン分析のための酵素
US20210228738A1 (en) 2017-07-17 2021-07-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Compositions and methods for increasing or enhancing transduction of gene therapy vectors and for removing or reducing immunoglobulins
CA3102152A1 (en) 2018-06-19 2019-12-26 Glykos Biomedical Oy Conjugate
CN112672765A (zh) 2018-06-29 2021-04-16 格莱科斯生物医药公司 结合物
US20230038373A1 (en) 2019-12-18 2023-02-09 Glykos Biomedical Oy Stabile conjugate
CN111044731B (zh) * 2019-12-19 2021-05-07 北京科技大学 脉冲温育免疫反应分离富集多肽药物中肽类杂质的方法
US11786605B2 (en) 2020-01-09 2023-10-17 Mersana Therapeutics, Inc. Site specific antibody-drug conjugates with peptide-containing linkers
EP4215208A1 (en) * 2020-09-21 2023-07-26 Shanghai Bao Pharmaceuticals Co., Ltd. Pharmaceutical combination and use thereof
KR20230137339A (ko) 2021-01-04 2023-10-04 메르사나 테라퓨틱스, 인코포레이티드 B7h4-표적화된 항체-약물 접합체 및 이의 사용 방법
EP4079848A1 (en) 2021-04-22 2022-10-26 Genovis Ab Immunoglobulin cleaving enzyme
CN115873833A (zh) * 2022-11-08 2023-03-31 上海泰昶生物技术有限公司 生产免疫球蛋白g降解酶的工程菌株和工艺

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0130228D0 (en) 2001-12-18 2002-02-06 Hansa Medica Ab Protein
GB0624874D0 (en) * 2006-12-13 2007-01-24 Hansa Medical Ab Treatment
US8323908B2 (en) * 2007-09-14 2012-12-04 Genovis Ab Method of assessing glycosylation state or functional quality of an IgG containing sample
GB0821100D0 (en) 2008-11-18 2008-12-24 Hansa Medical Ab Antibodies
WO2011039150A1 (en) * 2009-10-02 2011-04-07 Roche Glycart Ag A-fucosylation detection in antibodies

Also Published As

Publication number Publication date
KR102001427B1 (ko) 2019-07-18
WO2013037824A1 (en) 2013-03-21
JP2014531205A (ja) 2014-11-27
GB2509284A (en) 2014-06-25
JP6076349B2 (ja) 2017-02-08
CA2848230A1 (en) 2013-03-21
AU2012307461B2 (en) 2016-08-18
EA201490447A1 (ru) 2014-09-30
PT2756077T (pt) 2017-06-21
ZA201401840B (en) 2018-05-30
CN103946377A (zh) 2014-07-23
BR112014005816A2 (pt) 2020-12-29
CN103946377B (zh) 2016-10-05
GB201406321D0 (en) 2014-05-21
IN2014CN02163A (ru) 2015-05-29
US20140302519A1 (en) 2014-10-09
MX2014002906A (es) 2014-10-17
PL2756077T3 (pl) 2017-09-29
EP2756077A1 (en) 2014-07-23
KR20140081813A (ko) 2014-07-01
US9493752B2 (en) 2016-11-15
SG11201400505YA (en) 2014-04-28
ES2627334T3 (es) 2017-07-27
AU2012307461A1 (en) 2014-03-27
IL231410A0 (en) 2014-04-30
DK2756077T3 (en) 2017-07-03
EP2756077B1 (en) 2017-03-29
GB201115841D0 (en) 2011-10-26
CA2848230C (en) 2020-03-24
EA028490B1 (ru) 2017-11-30
NZ622172A (en) 2016-04-29
MX347727B (es) 2017-05-10

Similar Documents

Publication Publication Date Title
EA028490B8 (ru) Способ дегликозилирования иммуноглобулина
PH12017500785A1 (en) INTERFERON a2B VARIANTS
MX348071B (es) Variantes de fc.
NZ725398A (en) Variants of chymosin with improved milk-clotting properties
NZ702962A (en) Agse-deficient strain
PH12016500377A1 (en) Polypeptide for the hydrolytic cleavage of zearalenone and/or zearalenone derivatives, isolated polynucleotide thereof, and additive containing polypeptide, use of said polypeptide and method
WO2013027999A3 (ko) 열 안정성이 향상된 사이코스 에피머화 효소 변이체 및 이를 이용한 사이코스의 연속적 생산
MX346373B (es) Metodo para preparar harina de grano entero altamente dispersable con un contenido mejorado de avenantramida.
MX357484B (es) Cepa con deficit de amilasa.
MY171544A (en) A cell with reduced ppgppase activity
NZ731727A (en) Method for producing a protein hydrolysate
NZ596660A (en) Dig-5 insecticidal cry toxins
WO2012009026A3 (en) Novel methods of protein evolution
MX340248B (es) Celobiohidrolasa mutante.
WO2012018767A3 (en) Antibodies directed against il-17
AU2015348922A8 (en) Codon optimized polynucleotide for high level expression of CRM197
WO2013071295A3 (en) Transcript optimized expression enhancement for high-level production of proteins and protein domains
MY169049A (en) Microorganisms for producing putrescine and process for producing putrescine using them
WO2010002160A3 (ko) 돼지의 알파에스 1 카제인 유전자, 그 프로모터 및 그의 용도
MX365947B (es) Operaciones de cosecha mejoradas para proteinas recombinadas.
MX2012000532A (es) Procesamiento de anticuerpo enzimatico.
AU2015344324A8 (en) Endoxylanase mutant, enzyme composition for biomass decomposition, and method for producing sugar solution
NZ700199A (en) Epsilon toxin epitopes from clostridium perfringens with reduced toxicity
MX2022001383A (es) Celulas para inmunoterapia mejorada y usos de las mismas.
WO2011124925A3 (en) Polysaccharide degrading enzymes from coleoptera

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM RU